New research recently released by Cancer Research UK and Professor Peter Sasieni, from Queen Mary, University of London suggests that death rates from some types of cancer will fall by up to half within the next 20 years. This projected fall in the number of people expected to be killed by lung, breast and prostate cancers by 2030 is being credited to better treatment, such as regular screening and the success of anti-smoking campaigns.
Professor Sasieni said: “Our latest estimations show that for many cancers, adjusting for age, death rates are set to fall dramatically in the coming decades. What’s really encouraging is that the biggest cancer killers – lung, breast, bowel, and prostate – are part of this falling trend.”
The earlier lung cancer is detected, the greater the chances of successful treatment. Currently more than two-thirds of lung cancers are diagnosed at a late stage so survival rates for these patients are low. However, survival rates are higher the earlier diagnosis takes place. For this reason, Royal Brompton has developed a Lung Cancer Risk Assessment clinic.
The service is led by some of the UK’s leading specialists in respiratory medicine including the Royal Brompton’s medical director, Professor Timothy Evans; Dr Robert Wilson, the hospital’s director of respiratory medicine; Professor Michael Polkey, specialist in respiratory medicine and consultant physician, and Dr Pallav Shah, consultant physician and lead clinician for lung cancer services. The knowledge and expertise of these specialists and their teams are now available to anyone with concerns about the risk of lung cancer.